Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Murraya koenigii
South Asian culinary herb with significant anti-diabetic, anti-oxidant, and cholesterol-lowering properties.
Murraya koenigii, commonly known as curry leaf, is a South Asian culinary herb with significant anti-diabetic, antioxidant, and cholesterol-lowering properties. Its primary active compounds include carbazole alkaloids such as mahanine and koenimbine, along with flavonoids and phenolic acids. Traditionally used for diabetes, hair loss, and digestive stimulation, it is now supported by limited clinical evidence for glycemic control and lipid modulation.
The anti-diabetic effects are mediated through carbazole alkaloids that inhibit alpha-glucosidase and activate PPAR-gamma, enhancing insulin sensitivity. Mahanine and koenimbine exhibit antioxidant activity via Nrf2 pathway induction, reducing oxidative stress. Cholesterol-lowering actions involve HMG-CoA reductase inhibition and increased bile acid excretion, while hair growth promotion is linked to 5-alpha-reductase inhibition and improved scalp circulation.
South Asian culinary herb with significant anti-diabetic, anti-oxidant, and cholesterol-lowering properties.
Murraya koenigii, commonly known as curry leaf, is a South Asian culinary herb with significant anti-diabetic, antioxidant, and cholesterol-lowering properties. Its primary active compounds include carbazole alkaloids such as mahanine and koenimbine, along with flavonoids and phenolic acids. Traditionally used for diabetes, hair loss, and digestive stimulation, it is now supported by limited clinical evidence for glycemic control and lipid modulation.
The anti-diabetic effects are mediated through carbazole alkaloids that inhibit alpha-glucosidase and activate PPAR-gamma, enhancing insulin sensitivity. Mahanine and koenimbine exhibit antioxidant activity via Nrf2 pathway induction, reducing oxidative stress. Cholesterol-lowering actions involve HMG-CoA reductase inhibition and increased bile acid excretion, while hair growth promotion is linked to 5-alpha-reductase inhibition and improved scalp circulation.